This CME Activity has expired and is no longer available for credit.
Enhancing Glycemic Control in T2DM: Achieving Standards of Care in Primary Care: Case 2: Intensification of Treatment in a Patient With Symptoms of Diabetic Neuropathy
Patient Case Study
Time to Complete
November 9, 2012
November 8, 2013
0.50 / AMA PRA Category 1 Credit(s)TM
This program is sponsored by Joslin Diabetes Center.
Produced by Haymarket Medical Education
Supported by an educational grant from Lilly USA, LLC. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.
Inadequately managed diabetes leaves patients vulnerable to a host of complications that include diabetic peripheral neuropathy (DPN). Although it can be debilitatingly painful, DPN requires clinical attention even when asymptomatic or only mildly symptomatic. Because good glycemic control can stabilize or potentially improve this condition, DPN may help motivate patient engagement in self-care for diabetes.
Primary Care Physicians, Nurse Practitioners, Physician Assistants
After taking part in this educational activity, participants should be better able to:
Describe the interrelated pathophysiologic abnormalities that contribute to progressive beta‐cell failure and to the clinical manifestations and complications of T2DM
Apply current evidence‐based guidelines and expert recommendations for modifying and advancing therapy when glycemic goals for T2DM have not been met
Identify potential barriers to effective self‐management in patients with T2DM and devise practical strategies to help address those obstacles
Devise strategies that foster better control of glycemic patterns, particularly postprandial glucose levels, in people with T2DM
Richard S. Beaser, MD (Course Director/Chair) Medical Executive Director Professional Education Joslin Diabetes Center Associate Clinical Professor of Medicine Harvard Medical School Boston, MA
Richard S. Beaser, MD, has no relevant relationships to disclose.
Seth N. Braunstein, MD, PhD Associate Professor of Medicine Hospital of the University of Pennsylvania Philadelphia, PA
Seth N. Braunstein, MD, PhD, has no relevant relationships to disclose.
Patricia Bonsignore, RN, CDE, MS Manager, Clinical Education Programs, HCS Joslin Diabetes Center Boston, MA
Patricia Bonsignore, RN, CDE, MS, has no relevant relationships to disclose.
Robert E. Heinig, MD Chief of Endocrinology/Metabolism Rochester General Hospital Clinical Professor of Medicine University of Rochester School of Medicine Rochester, NY
Robert E. Heinig, MD, has received grants/research support from CV Therapeutics, Inc., Novartis, AstraZeneca, and Daiichi Sankyo, Inc., and consulting fees from CV Therapeutics, Inc., AstraZeneca, and Merck & Co., Inc.
Publishing Staff Disclosures
Jill Rovitzky Black, Melissa Johnson, and Anne Bardsley, Haymarket Medical Education, have nothing to disclose with regard to commercial support.
AMA PRA Category 1 Credit(s)TM
The Joslin Diabetes Center, Boston, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Joslin Diabetes Center designates this educational activity for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclosure of Unlabeled Use
This educational activity may contain discussion of approved and/or investigational uses of agents that are not indicated by the FDA. The Joslin Diabetes Center, Lilly USA, LLC, and Haymarket Medical Education do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Joslin Diabetes Center, Lilly USA, LLC, and Haymarket Medical Education. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
To obtain credit, a score of 70% or better is required. This CE is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the posttest survey, and have received your digital copy of your credit certificate. Your online certificate will be saved on myCME.com within your Profile/Exam History, which you can then access at any time.